investorscraft@gmail.com

Intrinsic Value of Spectrum Pharmaceuticals, Inc. (SPPI)

Previous Close$0.00
Intrinsic Value
Upside potential
Previous Close
$0.00
* Our model cannot be used “out of the box” for the valuation of this stock. You can still do your own valuation by changing the valuation input parameters.

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2022-12-31 and quarterly data as of 2023-03-31.

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year(a)2023202420252026202720282029203020312032203320342035203620372038203920402041204220432044204520462047

INCOME STATEMENT

Revenue growth rate, %-90.8NaN
Revenue, $10NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m83NaN
Operating income, $m-73NaN
EBITDA, $m-73NaN
Interest expense (income), $mNaN
Earnings before tax, $m-75NaN
Tax expense, $m0NaN
Net income, $m-75NaN

BALANCE SHEET

Cash and short-term investments, $m75NaN
Total assets, $m103NaN
Adjusted assets (=assets-cash), $m28NaN
Average production assets, $m0NaN
Working capital, $m58NaN
Total debt, $m30NaN
Total liabilities, $m75NaN
Total equity, $m28NaN
Debt-to-equity ratio1.093NaN
Adjusted equity ratio-1.645NaN

CASH FLOW

Net income, $m-75NaN
Depreciation, amort., depletion, $m-0NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m-97NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-0NaN
Free cash flow, $m-97NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m58
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount